EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification

Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee

Diabetes & Metabolism Journal · 31.01.2024 · 48 (1) · 83-96

DOI: 10.4093/dmj.2022.0363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 31.01.2024. Verfasst von Jinmi Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Vascular Calcification. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Daewoong Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucagon-like peptide-1 receptor agonist (GLP-1RA), which is a therapeutic agent for the treatment of type 2 diabetes mellitus, has a beneficial effect on the cardiovascular system.

Methods

To examine the protective effects of GLP-1RAs on proliferation and migration of vascular smooth muscle cells (VSMCs), A-10 cells exposed to angiotensin II (Ang II) were treated with either exendin-4, liraglutide, or dulaglutide. To examine the effects of GLP-1RAs on vascular calcification, cells exposed to high concentration of inorganic phosphate (Pi) were treated with exendin-4, liraglutide, or dulaglutide.

Results

Ang II increased proliferation and migration of VSMCs, gene expression levels of Ang II receptors AT1 and AT2, proliferation marker of proliferation Ki-67 (Mki-67), proliferating cell nuclear antigen (Pcna), and cyclin D1 (Ccnd1), and the protein expression levels of phospho-extracellular signal-regulated kinase (p-Erk), phospho-c-JUN N-terminal kinase (p-JNK), and phospho-phosphatidylinositol 3-kinase (p-Pi3k). Exendin-4, liraglutide, and dulaglutide significantly decreased the proliferation and migration of VSMCs, the gene expression levels of Pcna, and the protein expression levels of p-Erk and p-JNK in the Ang II-treated VSMCs. Erk inhibitor PD98059 and JNK inhibitor SP600125 decreased the protein expression levels of Pcna and Ccnd1 and proliferation of VSMCs. Inhibition of GLP-1R by siRNA reversed the reduction of the protein expression levels of p-Erk and p-JNK by exendin-4, liraglutide, and dulaglutide in the Ang II-treated VSMCs. Moreover, GLP-1 (9-36) amide also decreased the proliferation and migration of the Ang II-treated VSMCs. In addition, these GLP-1RAs decreased calcium deposition by inhibiting activating transcription factor 4 (Atf4) in Pi-treated VSMCs.

Conclusion

These data show that GLP-1RAs ameliorate aberrant proliferation and migration in VSMCs through both GLP-1Rdependent and independent pathways and inhibit Pi-induced vascular calcification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Vascular CalcificationHumansAngiotensin IIExenatideLiraglutideMuscle, Smooth, VascularProliferating Cell Nuclear AntigenGlucagon-Like Peptide ReceptorsPhosphatidylinositol 3-KinasesPhosphatesCell Proliferation

Stichwörter der Autor:innen

Angiotensin IICell migration inhibitionCell proliferationGlucagon-like peptide 1Muscle, smooth, vascular

Substanzen

Angiotensin IIExenatideLiraglutideProliferating Cell Nuclear AntigenGlucagon-Like Peptide ReceptorsPhosphatidylinositol 3-KinasesPhosphates

Autor:innen und Institutionen

  • Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Förderung

  • National Research Foundation of Korea
  • Daewoong Foundation

Zitieren

APA

Lee, J., Hong, S. W., Kim, M. J., Moon, S. J., Kwon, H., Park, S. E., Rhee, E. J., & Lee, W. Y. (2024). Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification. Diabetes & Metabolism Journal, 48(1), 83-96. https://doi.org/10.4093/dmj.2022.0363

Vancouver

Lee J, Hong SW, Kim MJ, Moon SJ, Kwon H, Park SE, et al. Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification. Diabetes & Metabolism Journal. 2024;48(1):83-96. doi:10.4093/dmj.2022.0363

BibTeX
@article{Lee2024,
  author = {Lee, Jinmi and Hong, Seok-Woo and Kim, Min-Jeong and Moon, Sun Joon and Kwon, Hyemi and Park, Se Eun and Rhee, Eun-Jung and Lee, Won-Young},
  title = {Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification},
  journal = {Diabetes & Metabolism Journal},
  year = {2024},
  volume = {48},
  number = {1},
  pages = {83--96},
  doi = {10.4093/dmj.2022.0363}
}
Kostenlos starten →